News
PRGO
31.23
+2.43%
0.74
99% Of This Perrigo Insider's Holdings Were Sold
Perrigo Company plc's (NYSE:PRGO) insiders sold shares in the last year. The biggest insider sale was by Murray Kessler for US$7.1m worth of shares at US$35.75 per share. In the last quarter, Perrigo insiders bought US$526k of shares. The company owns 0.5% of Perriga. But the company has sold more shares than it bought in the past 12 months. It's a good sign to see an insider sale of shares in a company.
Simply Wall St · 7h ago
Gerber, Perrigo sued over 'store-brand' infant formula prices
Gerber, Perrigo sued over 'store-brand' infant formula prices. The lawsuit says the formula makers illegally agreed to block competitors from cutting into the market for store-brand formula. The plaintiffs are four consumers of formula sold at Walmart, Walgreens and other retailers.
Reuters · 1d ago
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024
Perrigo Company plc plans to issue its first quarter 2024 financial results on Tuesday, May 7th, 2024. The earnings conference call will be available live via webcast. Perrigo is a leading provider of Consumer Self-Care Products and over-the-counter health and wellness solutions.
PR Newswire · 1d ago
Weekly Report: what happened at PRGO last week (0415-0419)?
Weekly Report · 2d ago
Heartland Mid Cap Value Fund Q1 2024 Portfolio Manager Commentary
Seeking Alpha · 04/17 14:55
Weekly Report: what happened at PRGO last week (0408-0412)?
Weekly Report · 04/15 09:15
Perrigo Price Target Maintained With a $42.00/Share by Canaccord Genuity
Dow Jones · 04/12 16:01
Perrigo Is Maintained at Buy by Canaccord Genuity
Dow Jones · 04/12 16:01
Canaccord Genuity Maintains Buy on Perrigo, Maintains $42 Price Target
Benzinga · 04/12 15:50
Perrigo Co Plc: Statement of changes in beneficial ownership of securities
Press release · 04/09 22:49
Opill and WNBA Team Up for Groundbreaking Partnership
Opill® is the first-ever daily birth control pill available without a prescription in the U.S. Opill will be an Associate Partner of the 2024 WNBA Draft. The WNBA is committed to building confidence, strength and health equity. The two brands will collaborate on a program to reach students on college campuses.
PR Newswire · 04/09 16:30
Upcoming Catalysts Position Perrigo For Sustained Long-Term Dividend Growth
Perrigo is a leading provider of over-the-counter medications and therapeutic products. The company has increased its dividends for 20 consecutive years. Infant formula woes will be resolved in 2024 and the company is poised to turn the corner. Perrigo has five potential catalysts in 2024 that could support a share price increase.
Seeking Alpha · 04/09 09:49
Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Canaccord Genuity boosted the price target for CervoMed Inc. The Walt Disney Company shares rose 1.1% to close at $118.38 on Friday. Susquehanna increased the price targets for Transocean Ltd. And Sealed Air Corporation.
Benzinga · 04/08 12:00
Perrigo Is Maintained at Overweight by Piper Sandler
Dow Jones · 04/08 11:26
Perrigo Price Target Raised to $39.00/Share From $35.00 by Piper Sandler
Dow Jones · 04/08 11:26
Perrigo’s Game-Changing Opill Gains Groundbreaking CVS Coverage: A Buy Rating Endorsement
TipRanks · 04/08 11:25
Weekly Report: what happened at PRGO last week (0401-0405)?
Weekly Report · 04/08 09:16
CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
CVS Health will cover the first over-the-counter birth control pill in the U.S. Without charge for many health plan sponsors. The move holds the potential to widen access to contraception. Last month, CVS Health and Walgreens announced plans to dispense the abortion pill mifepristone.
Benzinga · 04/05 16:53
Piper Sandler Remains a Buy on Perrigo Company (PRGO)
TipRanks · 04/05 10:47
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors. The U.S. FDA in July approved over-the-counter use of drug Opill. Opill is the first oral contraceptive in the country which can be purchased without prescription.
Reuters · 04/04 20:37
More
Webull provides a variety of real-time PRGO stock news. You can receive the latest news about Perrigo Co Plc through multiple platforms. This information may help you make smarter investment decisions.
About PRGO
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.